Therapeutic area

Ulcerative colitis

  • Payer objection/question responses in ulcerative colitis
  • Manuscript reporting the literature review and qualitative research project with ulcerative colitis subjects
  • Workshop and FAQ development in immunology in ulcerative colitis
  • Development of a payer value deck in immunology in ulcerative colitis
  • Payer value deck for a biosimilar in ulcerative colitis
  • Structured literature review and value dossier updates in a biosimilar for ulcerative colitis
  • PRO gap analysis and initial PRO dossier development in ulcerative colitis
  • Support in development and analyses of a patient support programme in ulcerative colitis

Upper tract urothelial carcinoma

  • HEOR and market access activities in upper tract urothelial carcinoma (UTUC)
  • Strategic consultancy for market access support in UTUC
  • Updates to a Health Impact Projection (HIP) model in locally advanced or metastatic urothelial cancer
  • Health economic data analysis in low-grade urothelial cancer
  • Health economic data analysis in upper tract urothelial carcinoma
  • Product monograph to support formulary inclusion in low grade upper tract urothelial carcinoma
  • Abstract and poster for economic analysis in low-grade up UTUC

Uterine fibroids

  • Consultation on the development of a diary to assess uterine fibroids
  • Assessment of a minimal clinically important difference in a uterine fibroid symptom and quality of life questionnaire
  • Design and pilot testing of an ePRO in uterine fibroids
  • Regulatory and statistical support for an FDA claim in women with uterine fibroids
  • Development of disease-specific modules for fibroids

Uveitis

  • Review of evidence requirements in uveitis for national and local reimbursement submissions in five European countries, with reviews of local language guidance
  • Strategic consultancy meeting on uveitis
  • Core value dossier in uveitis
  • Core value dossier in paediatric uveitis
  • Development of a HEOR strategy for uveitis
  • Structured literature review and value dossier updates in a biosimilar for uveitis
  • Payer value deck for a biosimilar in uveitis

Varicella

  • Update to payer value slide deck for varicella
  • Payer value deck for a varicella vaccine
  • Payer material development for vaccines in varicella
  • Response to payer questions deck in varicella
  • e-v@luate platform on vaccines for varicella
  • Value communication deck in varicella
  • Value communications support and manuscript on parental attitudes and knowledge of the varicella vaccination in Sweden

Vertigo

  • Communication of the economic burden of vertigo based on the REVERT registry
  • Manuscript on clinical outcomes in vertigo

Von Willebrand disease

  • Development and validation of a PRO measure in von Willebrand disease and haematology
  • Pre-validation work to inform a clinical trial in von Willebrand disease
  • In-trial validation of a PRO instrument in von Willebrand disease

Vulval cancer

  • Budget impact models in vulval cancer
  • Cost calculator to reflect change in patient estimation approach in vulval cancer

Warts

  • Development of a paediatric, adolescent and adult QoL measure of viral warts
  • ClinRO development for common warts
  • Development, evaluation, and regulatory support for the Physician Wart Assessment

Weight loss, weight gain, eating disorders, obesity and nutrition

  • Update of a budget impact model for an anorectic anti-obesity drug for cardiometabolic risk
  • Service impact model on cardiovascular complications in obesity
  • Value evidence story in obesity
  • Adaptation of a budget impact model on an anorectic anti-obesity drug for Latin America
  • Strategic guidance to support price and reimbursement in the EU in obesity
  • Global value dossier on an oral nutritional supplement
  • Statistical analysis and dossier development for localized fat reduction and body contouring
  • Value evidence story in obesity
  • Peripheral parenteral nutrition landscape review and manuscript for a medical device for surgical recovery
  • Gap analysis of three PRO questionnaires for obesity trials
  • Development of an instrument to assess subject perception of two gastric bands in obesity
  • Focus groups for the development of a treatment expectations questionnaire and the face and content validition of a visual analogue scale (VAS) for patients with obesity
  • PRO strategy in obesity
  • Development and validation of an adherence to diet questionnaire in obesity
  • Translation of an adherence to diet questionnaire in obesity
  • Outcomes consulting for a treatment in obesity
  • Item reduction for a questionnaire in obesity
  • Development of a PRO measure in binge eating disorder
  • Abstract and poster on binge eating disorder
  • Position paper on an adherence questionnaire in weight loss
  • Psychometric validation of a cohort study on adherence to lifestyle changes in weight loss and smoking cessation
  • Development and validation of a questionnaire to assess well-being changes in people who would like to lose weight and quit smoking
  • Manuscript on the development and validation of a lifestyle changes questionnaire for weight loss
  • Cognitive interviews for PRO instruments in localized fat reduction and body contouring
  • Development of a PRO questionnaire in abdominoplasty (tummy tuck)

X-linked hypophosphatemia (XLH)

  • Development of an FDA dossier in X-Linked Hypophosphatemia (XLH)
  • Validation activities of an FDA dossier in XLH
  • Psychometric validation of the Brief Pain Inventory (BPI) and Western Ontario and McMaster osteoarthritis index (WOMAC) in XLH using online survey data
  • Exploration of content validity of PROMIS items for use in children with XLH
  • Psychometric evaluation of the BPI-SF and WOMAC in XLH using phase III trial data

Yellow fever

  • Burden of disease literature review on yellow fever in the UK and Ireland